These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11745200)

  • 1. Immune function, telomerase, and angiogenesis in patients with primary, operable nonsmall cell lung carcinoma: tumor size and lymph node status remain the most important prognostic features.
    Toomey D; Smyth G; Condron C; Kay E; Conroy R; Foley D; Hong C; Hogan B; Toner S; McCormick P; Broe P; Kelly C; Bouchier-Hayes D
    Cancer; 2001 Nov; 92(10):2648-57. PubMed ID: 11745200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic and prognostic relevance of human telomerase reverse transcriptase mRNA expression detected in situ in patients with nonsmall cell lung carcinoma.
    Fujita Y; Fujikane T; Fujiuchi S; Nishigaki Y; Yamazaki Y; Nagase A; Shimizu T; Ohsaki Y; Kikuchi K
    Cancer; 2003 Sep; 98(5):1008-13. PubMed ID: 12942569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic significance of telomerase activity and hTERT mRNA expression in non-small cell lung cancer.
    Hara H; Yamashita K; Shinada J; Yoshimura H; Kameya T
    Lung Cancer; 2001 Nov; 34(2):219-26. PubMed ID: 11679180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancer.
    Yuan A; Yu CJ; Luh KT; Kuo SH; Lee YC; Yang PC
    J Clin Oncol; 2002 Feb; 20(4):900-10. PubMed ID: 11844810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
    Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Uchida Y
    Cancer; 2003 Jan; 97(2):457-64. PubMed ID: 12518370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
    O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
    Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Microvessel density and expressions of survivin and vascular endothelial growth factor in non-small cell lung cancer and their correlations to clinicopathologic features].
    Wang L; Li X; Li Y; Xue YW
    Ai Zheng; 2005 Jul; 24(7):823-6. PubMed ID: 16004808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cancer.
    Ge G; Wang A; Yang J; Chen Y; Yang J; Li Y; Xue Y
    J Exp Clin Cancer Res; 2016 Jan; 35():13. PubMed ID: 26791086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The intratumoral expression of vascular endothelial growth factor and interleukin-8 associated with angiogenesis in nonsmall cell lung carcinoma patients.
    Masuya D; Huang C; Liu D; Kameyama K; Hayashi E; Yamauchi A; Kobayashi S; Haba R; Yokomise H
    Cancer; 2001 Nov; 92(10):2628-38. PubMed ID: 11745198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. hTERT expression is a prognostic factor of survival in patients with stage I non-small cell lung cancer.
    Wang L; Soria JC; Kemp BL; Liu DD; Mao L; Khuri FR
    Clin Cancer Res; 2002 Sep; 8(9):2883-9. PubMed ID: 12231532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours.
    Lantuejoul S; Soria JC; Moro-Sibilot D; Morat L; Veyrenc S; Lorimier P; Brichon PY; Sabatier L; Brambilla C; Brambilla E
    Br J Cancer; 2004 Mar; 90(6):1222-9. PubMed ID: 15026805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of S100A13 protein is associated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer.
    Miao S; Qiu T; Zhao Y; Wang H; Sun X; Wang Y; Xuan Y; Qin Y; Jiao W
    Thorac Cancer; 2018 Sep; 9(9):1136-1144. PubMed ID: 30047626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic relevance of angiogenesis in stage III NSCLC receiving multimodality treatment.
    Kreuter M; Kropff M; Fischaleck A; Junker K; Gerss J; Heinecke A; Lindermann M; Reinmuth N; Berdel WE; Mesters RM; Thomas M
    Eur Respir J; 2009 Jun; 33(6):1383-8. PubMed ID: 19213790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma.
    Miyahara M; Tanuma J; Sugihara K; Semba I
    Cancer; 2007 Sep; 110(6):1287-94. PubMed ID: 17674352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer.
    Renyi-Vamos F; Tovari J; Fillinger J; Timar J; Paku S; Kenessey I; Ostoros G; Agocs L; Soltesz I; Dome B
    Clin Cancer Res; 2005 Oct; 11(20):7344-53. PubMed ID: 16243806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of angiogenesis in nonsmall-cell lung carcinoma.
    Offersen BV; Pfeiffer P; Hamilton-Dutoit S; Overgaard J
    Cancer; 2001 Apr; 91(8):1500-9. PubMed ID: 11301398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vascular endothelial growth factor expression and microvessel density in stage I-II non-small cell lung cancer and their prognostic significances].
    Zhu ZH; Rong TH; Zeng CG; Wu QL; Ma Y; Huang XP; Li BJ; Zhang PY; Zhao JM; Hu W; Zhang SY; Yu H; Ma GW; Zhang LJ; Wen ZS; Fu JH; Long H
    Ai Zheng; 2005 Jul; 24(7):865-9. PubMed ID: 16004817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis.
    Takanami I
    Oncol Rep; 2004 Oct; 12(4):849-53. PubMed ID: 15375511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer.
    Sirera R; Bremnes RM; Cabrera A; Jantus-Lewintre E; Sanmartín E; Blasco A; Del Pozo N; Rosell R; Guijarro R; Galbis J; Sánchez JJ; Camps C
    J Thorac Oncol; 2011 Feb; 6(2):286-90. PubMed ID: 21252717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationships among expressions of hTERT, MDR1, MRP mRNA, and C-myc protein in non-small cell lung cancer].
    Li L; Xiong YY; Liu L; Chen TX; Yao XF; Wang YW
    Ai Zheng; 2005 Jan; 24(1):53-7. PubMed ID: 15642200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.